Laboratory Service for Custom Purified Cdna-S and Proteins Tender, USA - 106555105

Procurement Summary

Country : USA

Summary : Laboratory Service for Custom Purified Cdna-S and Proteins

Deadline : 06 Sep 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 106555105

Document Ref. No. : NOI-NIAID-24-2226825

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Laboratories Nexelis Canada, Inc, located at 525 Boul Cartier O Laval, Qc H7V 3S8 Canada for the sequencing of custom purified CDNA-s and proteins.

The Laboratory of Infectious Diseases (LID) within the National Institute of Allergy and Infectious Diseases (NIAID) focuses on viral vaccine development, host immune response to viruses, and viral molecular biology and genetics. Major long-term programs are dedicated to understanding and preventing viral hepatitis, severe childhood respiratory diseases, and viral gastroenteritis. Newer programs focus on developing vaccines for pandemic influenza, West Nile virus, human metapneumovirus, and SARS-CoV—from basic research to clinical trials.​​​

The laboratory (the structural informatics unit) designs and studies the structure and epitopes display of influenza hemagglutinin antigens formulated into different mixtures of adjuvants to study influenza vaccines in terms of immunogenicity, biochemical and electron microscopic techniques. As such the purified codon-optimized cDNAs and hemagglutinin proteins will be used to carry out vaccine. Because high expression levels are needed the codon optimized cDNAs sequencing is needed to make hemagglutinin proteins for experimental studies. cDNAs and proteins from the vendor have been used by others in the field and have proven to be of sole unique high quality and allowed successful experiments and met the requirement of concentrated, purified, characterized cDNA and proteins for biochemical and animal studies.

The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS ...
Active Contract Opportunity
Notice ID : NOI-NIAID-24-2226825
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 30, 2024 03:11 pm EDT
Original Date Offers Due: Sep 06, 2024 12:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Sep 21, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: Q301 - REFERENCE LABORATORY TESTING
NAICS Code: 541380 - Testing Laboratories and Services

Place of Performance: Bethesda, MD 20892 USA

Documents

 Tender Notice